Adolescent Migraine Prevention Study

Migraines can be especially challenging for adolescents, affecting school, sports, and quality of life. This randomized, double-blind clinical trial is testing a novel treatment designed to reduce the frequency and intensity of migraines in adolescents.

We are currently enrolling adolescents (ages 12–17) who experience recurrent migraines. Participants must meet certain eligibility requirements, which will be reviewed during a screening visit.

• Study-related care, exams, and medication are provided at no cost
   
• Participants may receive compensation for time and travel
   
• Care is provided by experienced board-certified physicians and research staff
   

By joining this study, participants and families will:

• Gain access to a potential new treatment option
   
• Receive close medical monitoring and support from our research team
   
• Help advance migraine prevention research for adolescents worldwide
   

Your safety is our top priority. All study procedures follow strict FDA and IRB guidelines, and every participant is monitored throughout the trial.